I think the policies of at least the western countries—the U.K., the U.S., western Europe, Japan and Australia—are similar to what we do here. The intellectual property is owned either by the person who discovered it or the universities. By and large it's the same.
China is very regressive. They have not only tried to take ideas and patents from other people; they are now even preventing their own data from coming out. There's been a recent edict, in April, that will prevent any collaboration between Chinese and international investigators. The papers have to be reviewed and approved by the Chinese government. I don't know how this is going to play out.
I do want to add to one point you raised. One of my points was that we need to increase our investment research. A second equally important point is that we need to ensure a redistribution of that money so that the translational part, into clinical systems and patients and into populations, is well supported. That is even more miserably underfunded than the basic biomedical research.